why choose us

Clinical Trials Search

Showing 10,280 of 132,366 result(s)
Substituting SMSs for Provider-delivered Care to Improve Alcohol Use Outcomes

Status: COMPLETED

Condition: Alcohol Use Disorder, Mild

Interventions: One in-person session followed by standardized SMSs to reinforce the concepts learned in the first session.
The intervention follows principles o

Date: 2023-06-21

Evaluation of Thermal Outcome and Safety of Nuera Tight RF System

Status: COMPLETED

Condition: To Verify Tissue Heating and Temperature Stability and Safety Throughout RF Treatment Duration Appli

Interventions: monopolar radiofrequency device

Date: 2023-06-21

Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage

Status: Completed

Condition: Subarachnoid Hemorrhage, Aneurysmal

Interventions: Injection of local anesthetic (e.g.
Bupivacaine) into the pterygopalatine fossa to treat headache related to aneurysmal subarachnoid hemorrhage

Date: 2023-06-21

To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO

Status: COMPLETED

Condition: Dietary Supplement

Interventions: The investigational product (Oligomalt) dissolved in 300 ml water will be consumed over approximately 10 minutes in the morning of the study visit aft

Date: 2023-06-21

The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

Status: NOT_YET_RECRUITING

Condition: Prostate Cancer

Interventions: The precision screening intervention will consist of an interpreted prostate cancer genetic risk assessment (GRA) report, provided to the participant

Date: 2023-06-21

Basic and Applied Research on Extinction Bursts

Status: Completed

Condition: Problem Behavior

Interventions: In this condition, therapists will place destructive behavior on extinction and deliver no reinforcement for functional communication responses (FCRs)

Date: 2023-06-21

Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

Status: Completed

Condition: ADHD

Interventions: All subjects will be titrated to their optimal dose during the dose-optimization phase.
Possible doses are 6.25mg, 12.5mg, 18.75mg, 25.0mg, 31.25

Date: 2023-06-21

Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia

Status: Completed

Condition: Preeclampsia Postpartum

Interventions:

AT2R sensitivity: compound 21, and compound 21+ L-NAME (nitric oxide synthase inhibitor) are locally and acutely delivered to the cutaneous microva

Date: 2023-06-21

Goals for Epilepsy Clinic Visits Trial

Status: Completed

Condition: Drug Resistant Epilepsy

Interventions: Participants will be enrolled before a scheduled clinic appointment.
Following the clinic visit, the research staff will ask the patient to compl

Date: 2023-06-21

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Status: Completed

Condition: Breast Cancer

Interventions: Questionnaire items inquire about (1) the number of days of the week participants engage in walking for pleasure or exercise and (2) the number of min

Date: 2023-06-21